D'Orazio & Associates’s Fresenius Medical Care FMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$305K Buy
13,511
+4,606
+52% +$103K 0.04% 216
2026
Q1
$201K Buy
+8,905
New +$205K 0.03% 283
2021
Q4
Sell
-404
Closed -$14K 314
2021
Q3
$14K Buy
+404
New +$15.8K ﹤0.01% 473
2020
Q2
Sell
-100
Closed -$3K 343
2020
Q1
$3K Hold
100
﹤0.01% 279
2019
Q4
$4K Hold
100
﹤0.01% 291
2019
Q3
$3K Buy
+100
New +$3.54K ﹤0.01% 296
2015
Q4
Sell
-226
Closed -$10K 281
2015
Q3
$10K Buy
+226
New +$9.2K 0.01% 189

Other funds holding FMS

D'Orazio & Associates's FMS Position: Q2 2026 in Review

D'Orazio & Associates increased its Fresenius Medical Care (FMS) stake by 52% in Q2 2026, buying an estimated $103K and bringing the position to 13,511 shares worth $305K. The position accounts for 0.04% of the portfolio, ranked #216.

D'Orazio & Associates first reported a position in FMS in Q3 2015 and has held it in 7 quarters since. 233 funds tracked by Wall St. Rank hold FMS as of Q2 2026.

  • D'Orazio & Associates held 13,511 shares of Fresenius Medical Care worth $305K as of Q2 2026.
  • D'Orazio & Associates bought 4,606 Fresenius Medical Care shares in Q2 2026, an estimated $103K.
  • Fresenius Medical Care made up 0.04% of D'Orazio & Associates's portfolio in Q2 2026, its #216 holding.
  • D'Orazio & Associates first reported a position in Fresenius Medical Care in Q3 2015 and has held it in 7 quarters since.
  • 233 funds tracked by Wall St. Rank held Fresenius Medical Care as of Q2 2026.

Based on D'Orazio & Associates's 13F filing for Q2 2026, filed 28 Jul 2026.